SNDX•benzinga•
Citigroup Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $42
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 4, 2025 by benzinga